Position in BCYC
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$817,271
-$412,050 QoQ
Shares Held
176,136
+1.4% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FLAX POND CAPITAL, LLC holds $9,956,710 across 9 Biotechnology names. BCYC ranks #6 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
152,031 | $2,485,706 | |
| 2 | GPCR |
Structure Therapeutics Inc.
|
36,000 | $1,735,200 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
39,242 | $1,307,543 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
80,200 | $1,243,100 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
56,638 | $1,186,566 | |
| 6 | BCYC |
Bicycle Therapeutics PLC
This page
|
176,136 | $817,271 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
7,933 | $771,484 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
6,000 | $408,780 |
All Filings in BCYC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $817,271 | 176,136 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $1,229,321 | 173,633 | Shares | Sole | 2026-03-09 | |
| No filing history on record for this holder in this stock. | ||||||